Related content

Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia

By Djunic Irena   Virijevic Marijana   Novkovic Aleksandra   Djurasinovic Vladislava   Colovic Natasa   Vidovic Ana   Suvajdzic-Vukovic Nada   Tomin Dragica  

Hematology, Vol. 17, Iss. 2, 2012-03 ,pp. : 53-58

Maney Publishing

Access to resources Recommend Favorite

Surrogate endpoints for overall survival in advanced nonsmallcell lung cancer patients with mutations of the epidermal growth factor receptor gene

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 731-736

Spandidos Publications

Access to resources Recommend Favorite

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

By Lee C.-K.   Badros A.   Barlogie B.   Morris C.   Zangari M.   Fassas A.   van Rhee F.   Cottler-Fox M.   Jacobson J.   Thertulien R.   Muwalla F.   Mazher S.   Anaissie E.   Tricot G.  

Experimental Hematology, Vol. 31, Iss. 1, 2003-01 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite

Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1069-1075

Spandidos Publications

Access to resources Recommend Favorite

High expression of peroxiredoxin 4 affects the survival time of colorectal cancer patients, but is not an independent unfavorable prognostic factor

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 767-772

Spandidos Publications

Access to resources Recommend Favorite